Amanda Golaszewski
Acute Care · Morris Plains, NJNPI 1013551175
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 323 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 27.6% of the total. Among acute care clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 323 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$845
- Intercept Pharmaceuticals, Inc.$385
- QOL Medical, LLC$377
- Johnson & Johnson$294
- Aimmune Therapeutics, Inc.$293
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,591100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 113 | $1,546 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 63 | $845 |
| Intercept Pharmaceuticals, Inc. | 10 | $385 |
| QOL Medical, LLC | 18 | $377 |
| Johnson & Johnson | 15 | $294 |
| Aimmune Therapeutics, Inc. | 19 | $293 |
| Braintree Laboratories, Inc. | 10 | $200 |
| Ardelyx, Inc. | 11 | $179 |
| Nestle Healthcare Nutrition Inc. | 5 | $176 |
| Lilly USA, LLC | 8 | $143 |
| Janssen Scientific Affairs, LLC | 1 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $121 |
| Pfizer | 3 | $119 |
| Ipsen Biopharmaceuticals, Inc | 1 | $104 |
| Celltrion USA Inc. | 5 | $88 |
| Madrigal Pharmaceuticals | 5 | $88 |
| Regeneron Healthcare Solutions, Inc. | 5 | $85 |
| Ferring Pharmaceuticals Inc. | 4 | $79 |
| Vivus LLC | 4 | $70 |
| Evoke Pharma, Inc. | 3 | $56 |
| Sanofi | 3 | $54 |
| Bristol Myers Squibb | 3 | $43 |
| Edwards Lifesciences | 1 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Orphalan Inc | 2 | $29 |
| Merck | 1 | $19 |
| Novo Nordisk | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,607 in reported general payments places this provider in the 95th percentile of 656 acute care providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 22 | $62,938 |
| Sandostatin Lar DepotOctreotide Acetate,mi-Spheres | 12 | $52,770 |
| ZenpepLipase/Protease/Amylase | 13 | $14,011 |
| LinzessLinaclotide | 13 | $12,189 |
| MovantikNaloxegol Oxalate | 14 | $5,861 |
| Pantoprazole Sodium | 107 | $1,330 |
| Omeprazole | 49 | $637 |
| Famotidine | 75 | $527 |
| Hydrocortisone | 15 | $235 |
| Procto-Med HcHydrocortisone | 11 | $219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $1,546 | $75,12735 claims |
| Aimmune Therapeutics, Inc.Zenpep | $293 | $14,01113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 656 acute care providers in New Jersey.
Other acute care in Morris Plains
- Gabriella MagarelliHackensack$44K
- Per RosenkvistLivingston$29K
- Matthew OstroffPaterson$27K
- Ellen McCueNeptune$26K
- Suzanne ShuggLivingston$25K
- Maria Tedi CoronelHackensack$19K
- Hanane ChaibainouWestampton$16K
- Jennifer McCarthyNewark$16K
- Jennifer HarrarCamden$16K
- Vincent FroncekFlemington$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.